# Citryll

**Canonical:** https://apis.io/providers/citryll/  
**Website:** https://citryll.com  
**APIs profiled:** 0

Citryll is a biotech company developing CIT-013, a first‑in‑class monoclonal antibody targeting Neutrophil Extracellular Traps (NETs) to treat immune‑mediated inflammatory diseases such as rheumatoid arthritis and hidradenitis suppurativa. The company focuses on innovative therapies addressing the underlying biology of inflammation.

## Kin Score — 8.4 / 100 (minimal)

Scored 2026-10-09 under rubric 0.23.0.

| Facet | Score |
|---|---|
| Discoverability | 44.6 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 21.1 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 13.7 (matched via fallback).

## Agent readiness — 3.1 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | documented |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Citryll Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Immunology, Therapeutics, ClinicalTrials, Biopharma

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/citryll/). Scores are computed from the provider's own public artifacts under a published rubric.